Romiset 500mcg injection 6ml
Out of Stock • people bought this
Delivery : 2-4 days PAN India
Seller : Davadost pharma private limited
People who purchased Romiset 500mcg injection 6ml also bought
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to Romiset 500mcg injection 6ml
Romiset 500mcg Injection is used in the treatment of chronic immune thrombocytopenia in patients who have had an insufficient response to other treatments like corticosteroids, immunoglobulins, or splenectomy
Romiset 500mcg Injection is given by your doctor or nurse, who will make sure you get the right amount. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen.
Before getting this medicine, you should let your doctor know if you have or had a blood clot, bleeding problems, or have liver or kidney problems. Let your doctor also know about all other medications you are taking as some may affect or be affected by this medicine.
Benefits Of Romiset 500mcg injection 6ml
- In Chronic immune thrombocytopenia
Uses of Romiset 500mcg injection 6ml
- Chronic immune thrombocytopenia
Side Effects Of Romiset 500mcg injection 6ml
- Headache
- Joint pain
- Indigestion
- Indigestion
- Muscle pain
Safety Advice for Romiset 500mcg injection 6ml
- High risk
- Moderate risk
- Safe
There is limited information available on the use of Romiset 500mcg Injection in patients with liver disease. Please consult your doctor.
Romiset 500mcg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Romiset 500mcg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
